BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19378935)

  • 1. Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.
    Cormode DP; Chandrasekar R; Delshad A; Briley-Saebo KC; Calcagno C; Barazza A; Mulder WJ; Fisher EA; Fayad ZA
    Bioconjug Chem; 2009 May; 20(5):937-43. PubMed ID: 19378935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
    Shen ZT; Zheng S; Gounis MJ; Sigalov AB
    PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.
    Chen W; Vucic E; Leupold E; Mulder WJ; Cormode DP; Briley-Saebo KC; Barazza A; Fisher EA; Dathe M; Fayad ZA
    Contrast Media Mol Imaging; 2008; 3(6):233-42. PubMed ID: 19072768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.
    Sigalov AB
    Contrast Media Mol Imaging; 2014; 9(5):372-82. PubMed ID: 24729189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.
    Rui M; Guo W; Ding Q; Wei X; Xu J; Xu Y
    Int J Nanomedicine; 2012; 7():3751-68. PubMed ID: 22888232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression.
    Chen W; Cormode DP; Vengrenyuk Y; Herranz B; Feig JE; Klink A; Mulder WJ; Fisher EA; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):373-84. PubMed ID: 23433925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides.
    Yancey PG; Bielicki JK; Johnson WJ; Lund-Katz S; Palgunachari MN; Anantharamaiah GM; Segrest JP; Phillips MC; Rothblat GH
    Biochemistry; 1995 Jun; 34(24):7955-65. PubMed ID: 7794908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agents.
    Briley-Saebo KC; Geninatti-Crich S; Cormode DP; Barazza A; Mulder WJ; Chen W; Giovenzana GB; Fisher EA; Aime S; Fayad ZA
    J Phys Chem B; 2009 May; 113(18):6283-9. PubMed ID: 19361222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection.
    Cormode DP; Briley-Saebo KC; Mulder WJ; Aguinaldo JG; Barazza A; Ma Y; Fisher EA; Fayad ZA
    Small; 2008 Sep; 4(9):1437-44. PubMed ID: 18712752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
    Davidson WS; Lund-Katz S; Johnson WJ; Anantharamaiah GM; Palgunachari MN; Segrest JP; Rothblat GH; Phillips MC
    J Biol Chem; 1994 Sep; 269(37):22975-82. PubMed ID: 8083197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; LemaƮtre M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
    Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis.
    Marrache S; Dhar S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9445-50. PubMed ID: 23671083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis.
    Maiseyeu A; Mihai G; Kampfrath T; Simonetti OP; Sen CK; Roy S; Rajagopalan S; Parthasarathy S
    J Lipid Res; 2009 Nov; 50(11):2157-63. PubMed ID: 19017616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.
    Briley-Saebo KC; Shaw PX; Mulder WJ; Choi SH; Vucic E; Aguinaldo JG; Witztum JL; Fuster V; Tsimikas S; Fayad ZA
    Circulation; 2008 Jun; 117(25):3206-15. PubMed ID: 18541740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of macrophages via paramagnetic vesicles incorporating oxidatively tailored cholesterol ester: an approach for atherosclerosis imaging.
    Maiseyeu A; Mihai G; Roy S; Kherada N; Simonetti OP; Sen CK; Sun Q; Parthasarathy S; Rajagopalan S
    Nanomedicine (Lond); 2010 Nov; 5(9):1341-56. PubMed ID: 21128718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
    Amar MJ; D'Souza W; Turner S; Demosky S; Sviridov D; Stonik J; Luchoomun J; Voogt J; Hellerstein M; Sviridov D; Remaley AT
    J Pharmacol Exp Ther; 2010 Aug; 334(2):634-41. PubMed ID: 20484557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor.
    Lipinski MJ; Amirbekian V; Frias JC; Aguinaldo JG; Mani V; Briley-Saebo KC; Fuster V; Fallon JT; Fisher EA; Fayad ZA
    Magn Reson Med; 2006 Sep; 56(3):601-10. PubMed ID: 16902977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model class A and class L peptides increase the production of apoA-I-containing lipoproteins in HepG2 cells.
    Dashti N; Datta G; Manchekar M; Chaddha M; Anantharamaiah GM
    J Lipid Res; 2004 Oct; 45(10):1919-28. PubMed ID: 15292373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice.
    Bielicki JK; Zhang H; Cortez Y; Zheng Y; Narayanaswami V; Patel A; Johansson J; Azhar S
    J Lipid Res; 2010 Jun; 51(6):1496-503. PubMed ID: 20075422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.